These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 12750546)

  • 1. Recommendations for advancing development of acute stroke therapies: Stroke Therapy Academic Industry Roundtable 3.
    Fisher M;
    Stroke; 2003 Jun; 34(6):1539-46. PubMed ID: 12750546
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Trial design and reporting standards for intra-arterial cerebral thrombolysis for acute ischemic stroke.
    Higashida RT; Furlan AJ; Roberts H; Tomsick T; Connors B; Barr J; Dillon W; Warach S; Broderick J; Tilley B; Sacks D; ;
    Stroke; 2003 Aug; 34(8):e109-37. PubMed ID: 12869717
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enhancing the development and approval of acute stroke therapies: Stroke Therapy Academic Industry roundtable.
    Fisher M; Albers GW; Donnan GA; Furlan AJ; Grotta JC; Kidwell CS; Sacco RL; Wechsler LR;
    Stroke; 2005 Aug; 36(8):1808-13. PubMed ID: 16020764
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Future of neuroprotection for acute stroke: in the aftermath of the SAINT trials.
    Savitz SI; Fisher M
    Ann Neurol; 2007 May; 61(5):396-402. PubMed ID: 17420989
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stroke Treatment Academic Industry Roundtable: The Next Generation of Endovascular Trials.
    Jovin TG; Albers GW; Liebeskind DS;
    Stroke; 2016 Oct; 47(10):2656-65. PubMed ID: 27586682
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stroke Treatment Academic Industry Roundtable (STAIR) recommendations for maximizing the use of intravenous thrombolytics and expanding treatment options with intra-arterial and neuroprotective therapies.
    Albers GW; Goldstein LB; Hess DC; Wechsler LR; Furie KL; Gorelick PB; Hurn P; Liebeskind DS; Nogueira RG; Saver JL;
    Stroke; 2011 Sep; 42(9):2645-50. PubMed ID: 21852620
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The future of basic science research and stroke: hubris and translational stroke research.
    Lyden P
    Int J Stroke; 2011 Oct; 6(5):412-3. PubMed ID: 21951405
    [No Abstract]   [Full Text] [Related]  

  • 8. The case for modality-specific outcome measures in clinical trials of stroke recovery-promoting agents.
    Cramer SC; Koroshetz WJ; Finklestein SP
    Stroke; 2007 Apr; 38(4):1393-5. PubMed ID: 17332455
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Understanding history, and not repeating it. Neuroprotection for acute ischemic stroke: from review to preview.
    Grupke S; Hall J; Dobbs M; Bix GJ; Fraser JF
    Clin Neurol Neurosurg; 2015 Feb; 129():1-9. PubMed ID: 25497127
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Perspectives on neuroprotective stroke therapy.
    Schäbitz WR; Fisher M
    Biochem Soc Trans; 2006 Dec; 34(Pt 6):1271-6. PubMed ID: 17073800
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Future directions of acute ischaemic stroke therapy.
    Fisher M; Saver JL
    Lancet Neurol; 2015 Jul; 14(7):758-67. PubMed ID: 26067128
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Developing therapy for acute ischemic stroke.
    Fisher M
    Therapie; 2002; 57(6):564-8. PubMed ID: 12666264
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Stroke Recovery Trial Development Framework: Consensus-Based Core Recommendations from the Second Stroke Recovery and Rehabilitation Roundtable.
    Bernhardt J; Hayward KS; Dancause N; Lannin NA; Ward NS; Nudo RJ; Farrin A; Churilov L; Boyd LA; Jones TA; Carmichael ST; Corbett D; Cramer SC
    Neurorehabil Neural Repair; 2019 Nov; 33(11):959-969. PubMed ID: 31674274
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Toward wisdom from failure: lessons from neuroprotective stroke trials and new therapeutic directions.
    Gladstone DJ; Black SE; Hakim AM;
    Stroke; 2002 Aug; 33(8):2123-36. PubMed ID: 12154275
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recommendations for the relationship between sponsors and investigators in the design and conduct of clinical stroke trials.
    Donnan GA; Davis SM; Kaste M;
    Stroke; 2003 Apr; 34(4):1041-5. PubMed ID: 12649514
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Update of the stroke therapy academic industry roundtable preclinical recommendations.
    Fisher M; Feuerstein G; Howells DW; Hurn PD; Kent TA; Savitz SI; Lo EH;
    Stroke; 2009 Jun; 40(6):2244-50. PubMed ID: 19246690
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The only evidence based neuroprotective therapy for acute ischemic stroke: thrombolysis.
    Köhrmann M; Schellinger PD; Schwab S
    Best Pract Res Clin Anaesthesiol; 2010 Dec; 24(4):563-71. PubMed ID: 21619867
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stroke Treatment Academic Industry Roundtable X: Brain Cytoprotection Therapies in the Reperfusion Era.
    Savitz SI; Baron JC; Fisher M;
    Stroke; 2019 Mar; 50(4):1026–1031. PubMed ID: 31166683
    [No Abstract]   [Full Text] [Related]  

  • 19. Recommendations for clinical trial evaluation of acute stroke therapies.
    Stroke Therapy Academic Industry Roundtable II (STAIR-II)
    Stroke; 2001 Jul; 32(7):1598-606. PubMed ID: 11441207
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Magnetic resonance imaging criteria for thrombolysis in acute cerebral infarct.
    Hjort N; Butcher K; Davis SM; Kidwell CS; Koroshetz WJ; Röther J; Schellinger PD; Warach S; Østergaard L;
    Stroke; 2005 Feb; 36(2):388-97. PubMed ID: 15618445
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.